AJANTA PHARMA LTD. - 532331 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund & PACs AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of Postal Ballot Notice of the company published in Economic Times (English) & Navshakti (Marathi), on Saturday, 14th May 2022. AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsC allTranscriptQ4(Jan-Mar)2021-22.pdf AJANTA PHARMA LTD. - 532331 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith copy of the Annual Secretarial Compliance Report for year ended 31st March 2022 issued by M/s. Alwyn Dsouza & Co., Practicing Company Secretaries pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements), 2015. This is for your information and record AJANTA PHARMA LTD. - 532331 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Further to our letter dated 10th May 2022, please find enclosed herewith Postal Ballot Notice together with the Explanatory Statement seeking approval of members of the Company for issue of bonus shares. The Postal Ballot notice has been sent by e-mail on 13th May 2022 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Saturday, 14th May 2022, IST at 9.00 a.m. and will end on Sunday, 12th June 2022 IST at 5.00 p.m. You are requested to take the above information on record. Thanking you,
Buy Ajanta Pharma; target of Rs 2350: YES Securities
YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2350 in its research report date May 10, 2022. 
Yes Securities sees 42% upside in pharma stock that just announced bonus shares
Ajanta Pharma has recently announced bonus issue in the ratio of 1:2 AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Listing Regulations, please find enclosed copies of financial results of the Company for the quarter and year ended 31st March 2022 published in the following newspapers on 11th May 2022: 1. Mumbai edition of Economic Times and 2. Mumbai edition of Maharashtra Times; This is for your information and record. AJANTA PHARMA LTD. - 532331 - Audio Recording Of Earnings Call Conducted On 10Th May 2022
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link in the attachment. Written transcript of the same will be submitted in due course. This is for your information and records please.